Atıf Formatları
Resmetirom-eligible population among US adults: An estimation analysis based on NHANES 2017-March 2020.
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

P. Le Et Al. , "Resmetirom-eligible population among US adults: An estimation analysis based on NHANES 2017-March 2020.," Hepatology communications , vol.9, no.7, 2025

Le, P. Et Al. 2025. Resmetirom-eligible population among US adults: An estimation analysis based on NHANES 2017-March 2020.. Hepatology communications , vol.9, no.7 .

Le, P., Kaya, E., Phan, A., Yilmaz, Y., & Alkhouri, N., (2025). Resmetirom-eligible population among US adults: An estimation analysis based on NHANES 2017-March 2020.. Hepatology communications , vol.9, no.7.

Le, Phuc Et Al. "Resmetirom-eligible population among US adults: An estimation analysis based on NHANES 2017-March 2020.," Hepatology communications , vol.9, no.7, 2025

Le, Phuc Et Al. "Resmetirom-eligible population among US adults: An estimation analysis based on NHANES 2017-March 2020.." Hepatology communications , vol.9, no.7, 2025

Le, P. Et Al. (2025) . "Resmetirom-eligible population among US adults: An estimation analysis based on NHANES 2017-March 2020.." Hepatology communications , vol.9, no.7.

@article{article, author={Phuc Le Et Al. }, title={Resmetirom-eligible population among US adults: An estimation analysis based on NHANES 2017-March 2020.}, journal={Hepatology communications}, year=2025}